T
Toshinari Yamasaki
Researcher at Kyoto University
Publications - 122
Citations - 1503
Toshinari Yamasaki is an academic researcher from Kyoto University. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 22, co-authored 102 publications receiving 1141 citations.
Papers
More filters
Journal ArticleDOI
Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan.
Youichi Ohno,Masakatsu Sone,Nobuya Inagaki,Toshinari Yamasaki,Osamu Ogawa,Yoshiyu Takeda,Isao Kurihara,Hiroshi Itoh,Hironobu Umakoshi,Mika Tsuiki,Takamasa Ichijo,Takuyuki Katabami,Yasushi Tanaka,Norio Wada,Yui Shibayama,Takanobu Yoshimoto,Yoshihiro Ogawa,Junji Kawashima,Katsutoshi Takahashi,Megumi Fujita,Minemori Watanabe,Yuichi Matsuda,Hiroki Kobayashi,Hirotaka Shibata,Kohei Kamemura,Michio Otsuki,Yuichi Fujii,Koichi Yamamoto,Atsushi Ogo,Shintaro Okamura,Shozo Miyauchi,Tomikazu Fukuoka,Shoichiro Izawa,Takashi Yoneda,Shigeatsu Hashimoto,Toshihiko Yanase,Tomoko Suzuki,Takashi Kawamura,Yasuharu Tabara,Fumihiko Matsuda,Mitsuhide Naruse,Nagahama Study +41 more
TL;DR: In this paper, the authors compared the prevalence of CVD among patients with primary aldosteronism (PA) with that among age-, sex-, and blood pressure-matched essential hypertension patients and participants with hypertension in a general population cohort.
Journal ArticleDOI
Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.
Ichiro Yamauchi,Akihiro Yasoda,Shigemi Matsumoto,Yuichi Sakamori,Young Hak Kim,Motoo Nomura,Atsushi Otsuka,Toshinari Yamasaki,Ryoichi Saito,Morimasa Kitamura,Toshio Kitawaki,Masakatsu Hishizawa,Nobuko Kawaguchi-Sakita,Toshihito Fujii,Daisuke Taura,Masakatsu Sone,Nobuya Inagaki +16 more
TL;DR: By thyroid uptake of FDG-PET, overt thyroid irAEs could be predicted before nivolumab therapy, and these related to good prognosis in lung cancer but might be inconclusive in malignant melanoma.
Journal ArticleDOI
Exposure–Toxicity Relationship of Sorafenib in Japanese Patients with Renal Cell Carcinoma and Hepatocellular Carcinoma
Masahide Fukudo,Takuma Ito,Tomoyuki Mizuno,Keiko Shinsako,Etsuro Hatano,Shinji Uemoto,Tomomi Kamba,Toshinari Yamasaki,Osamu Ogawa,Hiroshi Seno,Tsutomu Chiba,Kazuo Matsubara +11 more
TL;DR: The results of this study suggest that the safety and pharmacokinetic profiles of sorafenib differ between Japanese cancer patients with RCC and HCC, and the serum sorAFenib concentration could be used as a guide to avoiding the development of severe HFSR while allowing prediction of the incidence of grade ≥2 hypertension.
Journal Article
Small cell carcinoma of the bladder
Toru Sakatani,Yosuke Shimizu,Yoshio Sugino,Toshinari Yamasaki,Masaaki Imamura,Yoshiyuki Matsui,Takahiro Inoue,Kazutoshi Okubo,Tomomi Kamba,Koji Yoshimura,Osamu Ogawa +10 more
TL;DR: In this article, the authors retrospectively reviewed the records of 11 patients with small cell carcinoma of the bladder, who were diagnosed at Kyoto University Hospital between June 1995 and November 2010.
Journal ArticleDOI
Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer.
Takayuki Goto,Naoki Terada,Takahiro Inoue,Takashi Kobayashi,Kenji Nakayama,Yoshiyuki Okada,Takeshi Yoshikawa,Yu Miyazaki,Masayuki Uegaki,Noriaki Utsunomiya,Yuki Makino,Shinji Sumiyoshi,Toshinari Yamasaki,Tomomi Kamba,Osamu Ogawa +14 more
TL;DR: Direct profiling of lipids in tissue using high‐resolution matrix‐assisted laser desorption/ionization imaging mass spectrometry (HR‐MALDI‐IMS) may provide molecular details that supplement tissue morphology.